351 related articles for article (PubMed ID: 15542433)
1. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells.
Bafico A; Liu G; Goldin L; Harris V; Aaronson SA
Cancer Cell; 2004 Nov; 6(5):497-506. PubMed ID: 15542433
[TBL] [Abstract][Full Text] [Related]
2. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors.
Miyoshi K; Rosner A; Nozawa M; Byrd C; Morgan F; Landesman-Bollag E; Xu X; Seldin DC; Schmidt EV; Taketo MM; Robinson GW; Cardiff RD; Hennighausen L
Oncogene; 2002 Aug; 21(36):5548-56. PubMed ID: 12165853
[TBL] [Abstract][Full Text] [Related]
3. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
Benhaj K; Akcali KC; Ozturk M
Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
[TBL] [Abstract][Full Text] [Related]
4. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.
González-Sancho JM; Aguilera O; García JM; Pendás-Franco N; Peña C; Cal S; García de Herreros A; Bonilla F; Muñoz A
Oncogene; 2005 Feb; 24(6):1098-103. PubMed ID: 15592505
[TBL] [Abstract][Full Text] [Related]
5. The Wnt connection to tumorigenesis.
Behrens J; Lustig B
Int J Dev Biol; 2004; 48(5-6):477-87. PubMed ID: 15349822
[TBL] [Abstract][Full Text] [Related]
6. Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.
Chen G; A J; Wang M; Farley S; Lee LY; Lee LC; Sawicki MP
Mol Cancer Res; 2008 Dec; 6(12):1894-907. PubMed ID: 19074834
[TBL] [Abstract][Full Text] [Related]
7. Diclofenac attenuates Wnt/beta-catenin signaling in colon cancer cells by activation of NF-kappaB.
Cho M; Gwak J; Park S; Won J; Kim DE; Yea SS; Cha IJ; Kim TK; Shin JG; Oh S
FEBS Lett; 2005 Aug; 579(20):4213-8. PubMed ID: 16051228
[TBL] [Abstract][Full Text] [Related]
8. Dominant-stable beta-catenin expression causes cell fate alterations and Wnt signaling antagonist expression in a murine granulosa cell tumor model.
Boerboom D; White LD; Dalle S; Courty J; Richards JS
Cancer Res; 2006 Feb; 66(4):1964-73. PubMed ID: 16488995
[TBL] [Abstract][Full Text] [Related]
9. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
Hämmerlein A; Weiske J; Huber O
Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
[TBL] [Abstract][Full Text] [Related]
10. The significance of the Wnt pathway in the pathology of human cancers.
Karim R; Tse G; Putti T; Scolyer R; Lee S
Pathology; 2004 Apr; 36(2):120-8. PubMed ID: 15203747
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.
Pendás-Franco N; Aguilera O; Pereira F; González-Sancho JM; Muñoz A
Anticancer Res; 2008; 28(5A):2613-23. PubMed ID: 19035286
[TBL] [Abstract][Full Text] [Related]
12. Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia.
Simon M; Grandage VL; Linch DC; Khwaja A
Oncogene; 2005 Mar; 24(14):2410-20. PubMed ID: 15735743
[TBL] [Abstract][Full Text] [Related]
13. Wnt/beta-catenin signaling in cancer stemness and malignant behavior.
Fodde R; Brabletz T
Curr Opin Cell Biol; 2007 Apr; 19(2):150-8. PubMed ID: 17306971
[TBL] [Abstract][Full Text] [Related]
14. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
Shan BE; Wang MX; Li RQ
Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications.
Chen G; Shukeir N; Potti A; Sircar K; Aprikian A; Goltzman D; Rabbani SA
Cancer; 2004 Sep; 101(6):1345-56. PubMed ID: 15316903
[TBL] [Abstract][Full Text] [Related]
16. Activation of Wnt/beta-catenin/Tcf signaling in mouse skin carcinogenesis.
Bhatia N; Spiegelman VS
Mol Carcinog; 2005 Apr; 42(4):213-21. PubMed ID: 15765534
[TBL] [Abstract][Full Text] [Related]
17. Wnt signaling through canonical and non-canonical pathways: recent progress.
Widelitz R
Growth Factors; 2005 Jun; 23(2):111-6. PubMed ID: 16019432
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas.
Hendrix ND; Wu R; Kuick R; Schwartz DR; Fearon ER; Cho KR
Cancer Res; 2006 Feb; 66(3):1354-62. PubMed ID: 16452189
[TBL] [Abstract][Full Text] [Related]
19. Quercetin, a potent inhibitor against beta-catenin/Tcf signaling in SW480 colon cancer cells.
Park CH; Chang JY; Hahm ER; Park S; Kim HK; Yang CH
Biochem Biophys Res Commun; 2005 Mar; 328(1):227-34. PubMed ID: 15670774
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between pRb/E2F and Wnt/beta-catenin pathways: E2F1 induces axin2 leading to repression of Wnt signalling and to increased cell death.
Hughes TA; Brady HJ
Exp Cell Res; 2005 Feb; 303(1):32-46. PubMed ID: 15572025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
